Second Edition of “Breast Cancer: Global Quality Care Matters” Released by Isabel Mestres
The second edition of *Breast Cancer: Global Quality Care Matters*, authored by Isabel Mestres, a senior oncologist and global health advocate, was released on April 5, 2024, according to the book’s publisher, Oxford University Press. The updated volume expands on the first edition’s focus on equitable breast cancer care, incorporating recent advancements in treatment protocols and global health policy reforms, according to a press release from the publisher.
What Is the Second Edition About?
The second edition integrates data from the World Health Organization’s (WHO) 2023 report on cancer care disparities, emphasizing strategies to improve access to early detection and personalized therapies in low-resource settings. Mestres, who serves as a consultant for the WHO’s Global Cancer Observatory, states in an interview with *The Lancet Oncology* that the book “addresses gaps in treatment adherence and cultural barriers to care.” The text includes case studies from sub-Saharan Africa, Southeast Asia, and rural Latin America, highlighting localized solutions to systemic challenges.
Why Is This Release Significant?
The release coincides with the WHO’s updated guidelines on breast cancer screening, which recommend expanded use of mobile diagnostic units in underserved regions. According to a 2023 study in *JAMA Oncology*, early detection rates in low-income countries remain below 40%, compared to over 85% in high-income nations. Mestres’ book provides a framework for implementing these guidelines, including partnerships with local healthcare providers and telemedicine platforms, as detailed in a report by the Global Health Council.
How Does the New Edition Differ From the First?
The second edition introduces a chapter on genomic testing and its role in tailoring therapies, reflecting advances in precision medicine. It also includes updated statistics from the International Agency for Research on Cancer (IARC), which reported a 12% increase in breast cancer incidence globally between 2018 and 2022. Unlike the first edition, which focused primarily on clinical protocols, the new version emphasizes policy advocacy, with sections on funding models and public health campaigns, according to a review in *Cancer Epidemiology, Biomarkers & Prevention*.
What Are the Implications for Global Health?
Health experts note that the book’s emphasis on equity aligns with the United Nations’ Sustainable Development Goal 3, which aims to reduce premature mortality from cancer by 2030. Dr. Linda Molnar, a breast cancer researcher at the University of California, San Francisco, who was not involved in the book’s creation, told *The New York Times* that “Mestres’ work bridges the gap between academic research and real-world application, particularly in regions with limited infrastructure.”
Where Can the Book Be Accessed?
The second edition is available for purchase through major retailers, including Amazon and Barnes & Noble, as well as via the Oxford University Press website. A portion of proceeds will fund the Breast Cancer Equity Initiative, a nonprofit founded by Mestres in 2020 to support cancer care in developing nations, according to the organization’s official press release.